Agency / Source: Dentsu

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Dentsu Announces Dentsu Ventures Investment in Twist Bioscience, a Company Providing High-Throughput DNA Synthesis for Multiple Industries in the Unit - Dentsu, Inc. announced that Dentsu Ventures Global Fund I (hereinafter
Dentsu Announces Dentsu Ventures Investment in Twist Bioscience, a Company Providing High-Throughput DNA Synthesis for Multiple Industries in the Unit

 

PRZOOM - /newswire/ - Tokyo, Japan, 2017/11/15 - Dentsu, Inc. announced that Dentsu Ventures Global Fund I (hereinafter "Dentsu Ventures") has made an investment in Twist Bioscience Corporation - twistbioscience.com / Dentsu-V.com. Tokyo: 4324

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Marketing / Newswire / PR Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Dentsu, Inc. (President & CEO: Toshihiro Yamamoto; Head Office: Tokyo; Capital: 74,609.81 million yen) announced today that Dentsu Ventures Global Fund I (hereinafter "Dentsu Ventures"), the Company's corporate venture capital fund, has made an investment in Twist Bioscience Corporation (Head Office: San Francisco; CEO: Emily LeProust (hereinafter,"Twist Bioscience"), a U.S. company providing high-throughput DNA synthesis for multiple industries.

Twist Bioscience (twistbioscience.com) has developed proprietary technologies that enable DNA synthesis to be performed in a highly efficient manner, more quickly and at lower cost than conventional production processes, and provides DNA in response to a variety of client needs. Rather than conventional plastic plates, Twist Bioscience synthesizes DNA on silicon plates it has developed in house. This approach achieves breakthrough increases in efficiency, speed and quality of DNA production, compared with conventional DNA synthesis processes. The company serves customers in an array of markets including drug discovery, new materials production, agriculture, academia and medical diagnosis. Going forward, the company plans to utilize its DNA synthesis technology to expand into the data storage business, leveraging its efforts in the drug discovery and development business.

Dentsu Ventures (dentsu-v.com) plans to support Twist Bioscience's partnership strategy for developing potential technologies utilized on a variety of fronts, from pharmaceutical production to biocomputing. By forming alliances with Dentsu Group clients and partner companies, Dentsu Ventures will support Twist Bioscience's innovative business development.

Profiles of Twist Bioscience and Dentsu Ventures are provided below.
Profile of Twist Bioscience
Company Name: Twist Bioscience Corporation
Location: San Francisco, California, U.S.A.
Representative: Emily LeProust (CEO)
Line of Business: Providing High-Throughput DNA Synthesis for Multiple Industries

Profile of Dentsu Ventures
Name: Dentsu Ventures Global Fund I
Total Fund Capital: 10.0 billion yen
Date of Establishment: April 2015
Period of Operation: Slated for 10-year period, through March 2025
Investment Regions: Global investments with a focus on the U.S., Europe Japan and Asia
Investment Stages: Balanced, wide-ranging investments with the focus on seed and early stage investments, but also including mid-stage and later-stage investments.
Investment Areas:
(1) Areas that can change the marketing and communication business in a broad sense
(2) New areas other than the above that have a high potential for innovation

Investment-related enquiries: Dentsu Ventures
E: info[.]dentsu-v.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Marketing / Newswire / PR Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Dentsu

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Marketing / Newswire / PR articles,
CATCH Visitors via Your Competitors Announcements!


Dentsu Announces Dentsu Ventures Investment in Twist Bioscience, a Company Providing High-Throughput DNA Synthesis for Multiple Industries in the Unit

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Shusaku Kannan - Dentsu.co.jp 
+81 3-6216-8042 s.kannan[.]dentsu.co.jp
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Dentsu securities in any jurisdiction including any other companies listed or named in this release.

Marketing / Newswire / PR via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Dentsu / Company Profile


Read Marketing / Newswire / PR Most Recent Related Press Releases:

Leading Press Release Newswire and Market Research Report Distribution Service Network Celebrates 15 Year Anniversary
Frost & Sullivan and TERI’s Sustainability 4.0 Awards 2021 Honor Companies Embedding Sustainability with Economic Value Creation
The Franchise Group Creative Marketing Agency Expands Video Studio and Creative Services in Acushnet, Massachusetts
Fortune and Great Place to Work® Name Launch Potato A Best Place to Work for a Second Time
Launch Potato Named a Top 100 Best Company for the 4th Consecutive Year
Global Adoption of Marketing Automation Solutions Skyrockets Thanks to Pandemic-Fueled Digitization Finds Frost & Sullivan
Limelon Advertising, Co. Acquires Newswire Distribution Service Domain Name - Newswire.Today
Launch Potato Certified Great Place to Work 2020
Dentsu Announces iProspect Acquisition of Direct-to-Consumer Marketing Agency MuteSix
Dentsu Enhances Data and Analytics Services with Acquisition of India-based Ugam

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com

Visit  Institute of Computer Vision/ Comp. Sciences







 
  ©2022 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today